- Home
- VCIG vs CING Comparison
VCIG vs CING Comparison
Compare VCIG & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCIG
- CING
- Stock Information
- Founded
- VCIG 2013
- CING 2012
- Country
- VCIG Malaysia
- CING United States
- Employees
- VCIG 58
- CING N/A
- Industry
- VCIG Diversified Commercial Services
- CING Biotechnology: Pharmaceutical Preparations
- Sector
- VCIG Consumer Discretionary
- CING Health Care
- Exchange
- VCIG Nasdaq
- CING Nasdaq
- Market Cap
- VCIG 21.7M
- CING 26.7M
- IPO Year
- VCIG 2023
- CING 2021
- Fundamental
- Price
- VCIG $0.81
- CING $4.04
- Analyst Decision
- VCIG
- CING Strong Buy
- Analyst Count
- VCIG 0
- CING 4
- Target Price
- VCIG N/A
- CING $30.67
- AVG Volume (30 Days)
- VCIG 3.8M
- CING 173.5K
- Earning Date
- VCIG 08-26-2025
- CING 08-26-2025
- Dividend Yield
- VCIG N/A
- CING N/A
- EPS Growth
- VCIG N/A
- CING N/A
- EPS
- VCIG 54.73
- CING N/A
- Revenue
- VCIG $27,819,290.00
- CING N/A
- Revenue This Year
- VCIG N/A
- CING N/A
- Revenue Next Year
- VCIG N/A
- CING N/A
- P/E Ratio
- VCIG $0.01
- CING N/A
- Revenue Growth
- VCIG 36.99
- CING N/A
- 52 Week Low
- VCIG $0.75
- CING $3.02
- 52 Week High
- VCIG $264.60
- CING $20.83
- Technical
- Relative Strength Index (RSI)
- VCIG 32.75
- CING 40.42
- Support Level
- VCIG $0.75
- CING $3.50
- Resistance Level
- VCIG $0.93
- CING $4.31
- Average True Range (ATR)
- VCIG 0.10
- CING 0.46
- MACD
- VCIG 0.05
- CING -0.15
- Stochastic Oscillator
- VCIG 11.08
- CING 24.11
About VCIG VCI Global Limited
VCI Global Ltd is a holding company. The principal activities of the Company and its subsidiaries are the provision of business Strategy consultancy and technology development. The firm organized its consulting services into three main segments: Business Strategy Consultancy; Technology development, solutions and consultancy; and Others. It derives the majority of its revenue from the Business Strategy Consultancy segment, which focuses on listing solutions, investor relations, and boardroom strategies consultancy.
About CING Cingulate Inc.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.